Pfizer Scientist Dies

Genetics researcher and senior vice president of the pharmaceutical giant, David Cox, has passed away unexpectedly at age 66.

By | January 25, 2013

FLICKR, Montgomery County Planning CommissionThe head genetics researcher at Pfizer Corporation’s San Francisco office, David Cox, died unexpectedly, the company announced this week (January 22). He was 66 years old. Cox, a senior vice president who joined in the multinational pharmaceutical company in 2008, was considered a visionary leader in drug development and biotech innovations.

“David Cox was a world-renowned geneticist and a highly valued leader here at Pfizer,” a Pfizer spokeswoman said in a statement, reported by Forbes. “As the company’s lead geneticist based at our Rinat facility in San Francisco, David was a driving force in shaping Pfizer’s strategy on Precision Medicine, as well as our vision for the future of biomedical innovation. Our thoughts and sympathies are with David’s family during this difficult time, and he will be truly missed.”

Before joining Pfizer, Cox trained as a pediatrician and became professor of genetics and pediatrics at Stanford University as well as the co-director of the Stanford Genome Center. After being involved in the project to sequence the human genome, he went on to co-found and become the chief scientific officer of the personal genomics firm, Perlegen, which is now defunct.

Early reports did not include the cause of his death.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech